Survival Prediction Models for Ovarian Cancer Patients with Lung Metastasis: A Retrospective Cohort Study Based on SEER Database

被引:0
作者
Dingxi Li
Mengli Zhang
Huiying Zhang
机构
[1] Tianjin Medical University General Hospital,Department of Gynecology
[2] Affiliated Cancer Hospital of Zhengzhou University,Department of Gynecology
来源
International Journal of Computational Intelligence Systems | / 16卷
关键词
Ovarian cancer; Lung metastasis; Prognosis; SEER;
D O I
暂无
中图分类号
学科分类号
摘要
To develop a random forest prediction model for the and short- and long-term survival of ovarian cancer patients with lung metastasis. This retrospective cohort study enrolled primary ovarian cancer patients with lung metastasis from the surveillance, epidemiology and end results (SEER) database (2010–2015). All eligible women were randomly divided into the training (n = 1357) and testing set (n = 582). The outcomes were 1-, 3- and 5-year survival. Predictive factors were screened by random forest analysis. The prediction models for predicting the 1-, 3- and 5-year survival were conducted using the training set, and the internal validation was carried out by the testing set. The performance of the models was evaluated with area under the curve (AUC), accuracy, sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV). The subgroups based on the pathological classification further assessed the model’s performance. Totally 1345 patients suffered from death within 5 years. The median follow-up was 7.00 (1.00, 21.00) months. Age at diagnosis, race, marital status, tumor size, tumor grade, TNM stage, brain metastasis, liver metastasis, bone metastasis, etc. were predictors. The AUCs of the prediction model for the 1-, 3-, 5-year survival in the testing set were 0.849 [95% confidence interval (CI): 0.820–0.884], 0.789 (95% CI 0.753–0.826) and 0.763 (95% CI 0.723–0.802), respectively. The results of subgroups on different pathological classifications showed that the AUCs of the model were over 0.7. This random forest model performed well predictive ability for the short- and long-term survival of ovarian cancer patients with lung metastasis, which may be beneficial to identify high-risk individuals for intelligent medical services.
引用
收藏
相关论文
共 56 条
[1]  
Siegel RL(2022)Cancer statistics, 2022 CA Cancer J. Clin. 72 7-33
[2]  
Miller KD(2019)Ovarian cancer: pathogenesis and current recommendations for prophylactic surgery J. Turk. Ger. Gynecol. Assoc. 20 47-54
[3]  
Fuchs HE(2018)Ovarian cancer statistics, 2018 CA Cancer J. Clin. 68 284-296
[4]  
Budiana ING(2020)Ovarian, uterine and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes Clin. Exp. Metastasis 37 107-113
[5]  
Angelina M(2018)Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients Gynecol. Oncol. 150 460-465
[6]  
Pemayun TGA(2022)Prediction for 2-year mortality of metastatic ovarian cancer patients based on surveillance, epidemiology, and end results database Front. Surg. 9 609-2885
[7]  
Torre LA(2021)Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study BMC Cancer 21 2877-3409
[8]  
Trabert B(2021)Application of machine learning in prediction of chemotherapy resistant of ovarian cancer based on gut microbiota J. Cancer. 12 3395-68
[9]  
Desantis CE(2022)Computed tomography-based radiomics machine learning classifiers to differentiate type I and type II epithelial ovarian cancers Eur. Radiol. 153 60-3139
[10]  
Gardner AB(2022)A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer Comput. Biol. Med. 15 1057-6397